OT notes · Urology

Transurethral resection of bladder tumour (TURBT)

Usual anaesthesia
Spinal or general; general with muscle relaxant for lateral wall tumours
Position
Modified dorsal lithotomy
Setting
elective

Operative note template for transurethral resection of a bladder tumour, with a filled example for a solitary lateral wall papillary tumour resected under general anaesthesia with muscle relaxation.

Download printable PDFFree. Just log in with your Google (Gmail) account.

Blank template

Follow this order in the case sheet. Tick the options that apply and fill the blanks.

Patient and case

  1. Name / Age / Sex
  2. UHID / IP no. / Ward-Bed
  3. Date of surgery / OT no.
  4. CaseElectiveEmergency (non-elective)if emergency, state urgency and reason
  5. Timesin OT ___ anaesthesia start ___ incision ___ closure ___ out of OT ___

Team

  1. Operating surgeonname, designation
  2. Assistant(s)
  3. Supervising consultantpresent in OT / available / not applicable
  4. Steps done by the residentwhole procedure / named steps, under whose supervision
  5. Anaesthetist
  6. Scrub nurse / circulating nurse

Diagnosis and procedure

  1. Pre-operative diagnosis
  2. Post-operative diagnosis
  3. Procedure planned
  4. Procedure performedif different from plan, state why
  5. Extra procedure done and reason'none' if none. Only to save life or health if not consented

Consent and safety checks

  1. Informed consentGeneralProcedure-specificHigh-riskAnaesthesiain a language the patient understands: language ___ witness ___
  2. Site / side markedYesNot applicable
  3. WHO Surgical Safety ChecklistSign inTime outSign out
  4. Antibiotic prophylaxisdrug, dose, route, time given before incision
  5. VTE prophylaxisMechanicalPharmacologicalNot indicated

Risks to explain in the consent for this operation

  • bleeding and clot retention
  • bladder perforation, which may need catheter drainage or open or laparoscopic repair
  • obturator nerve jerk during lateral wall resection
  • ureteric orifice injury or obstruction, sometimes needing a stent
  • urinary infection
  • urinary retention and irritative symptoms
  • incomplete resection and need for a second-look resection
  • recurrence of tumour and need for repeat cystoscopies

Pre-operative details for this operation

  1. Presentationhaematuria (painless / clots), incidental finding, recurrence on check cystoscopy
  2. ImagingUSG / CT urography: size, site, number, hydronephrosis, upper tract lesions
  3. Primary or recurrentif recurrent: previous stage, grade, intravesical therapy
  4. Urine culture and cytologyresult and date
  5. Anticoagulants / antiplateletsdrug and date stopped
  6. Smoking history

Anaesthesia and position

  1. AnaesthesiaGeneral with muscle relaxantSpinalwrite why, if lateral wall tumour
  2. PositionModified dorsal lithotomy
  3. Bimanual examination under anaesthesiaNo palpable massMobile massFixed massbefore and after resection
  4. Energy and irrigantMonopolar with sterile waterMonopolar with 1.5% glycineBipolar with 0.9% salineLasergenerator settings; total irrigant volume
  5. Resectoscope and lensessheath size (Fr); 30 and 70 degree lenses

Operative findings

  1. Urethra and prostatic urethranormal / tumour / stricture
  2. Number of tumours
  3. Site of each tumourwall (right / left lateral, posterior, trigone, dome, anterior, bladder neck), relation to ureteric orifices; draw a bladder diagram
  4. Size of largest tumourin cm (compare with loop width)
  5. AppearancePapillarySessileNodularFlat red patch (suspect CIS)
  6. Ureteric orificesboth seen, efflux clear / involved
  7. Rest of bladdertrabeculation, diverticulum (tumour inside?), stones
  8. Enhanced cystoscopyNot usedNarrow-band imagingBlue lightextra lesions found

Procedure (steps)

  1. Cystourethroscopyfull survey with 30 and 70 degree lenses
  2. TechniqueLoop resection (piecemeal)En bloc resectionCold cup biopsyFulguration only
  3. Exophytic part resectedfrom periphery in layers for large sessile tumours; in one swipe for small papillary ones
  4. Tumour base resecteddepth: into muscularis propria but not through it
  5. Base sample sent separatelyYesNo
  6. Resection near ureteric orificeNot neededDone with pure cut current
  7. Other biopsiesrandom / suspicious areas / prostatic urethra; site of each
  8. Chip evacuationEllik evacuator
  9. Haemostasisedges and base coagulated; checked with flow off and bladder emptied
  10. Resection visually completeYesNo (what was left and why)
  11. PerforationNoneExtraperitonealIntraperitonealSuspected, cystogram donefat seen? action taken
  12. Resection timeminutes

Closure, drains and dressing

  1. Cathetersize (Fr), two-way / three-way, balloon volume in ml
  2. Continuous bladder irrigationNot neededStarted (fluid, rate)
  3. Single post-operative intravesical chemotherapyGiven (drug, dose, time, dwell time)Not given (reason: perforation / heavy bleeding / other)
  4. Ureteric stentNonePlaced (side, size, length, removal date)

Specimens and implants

  1. Tumour chipsone container per site, labelled with site; weight in grams
  2. Tumour base / deep muscleseparate labelled container
  3. Other biopsieseach in its own labelled container
  4. Requisitionclinical details, site of each specimen, primary or recurrent

End of procedure

  1. Estimated blood lossml
  2. IV fluids and blood / products givenfluids (ml); blood: type, units, bag nos.
  3. Swab, needle and instrument countCorrectIncorrect: action taken
  4. Intra-operative complications / difficultieswhat happened and what was done; 'none' if none
  5. Implant stickersNo implantAffixed in case sheet, OT register and for discharge summary
  6. Condition at end of surgery / shifted toPACUWardICU/HDU

Post-operative orders

  1. Vitalshourly for 4 hours
  2. Urine colour and catheter drainagewatch for clots; hand wash with catheter-tip syringe if blocked
  3. Continuous bladder irrigationif started: fluid, rate, stop when clear
  4. Abdominal distension or painmay mean perforation: inform at once
  5. Intravesical chemotherapyif ordered: drug, dose, dwell time, then drain; handle as cytotoxic
  6. Catheter removal and voiding trialday planned
  7. Serum sodiumif glycine or water used for a long resection
  8. HPE follow-update to review report; need for second-look resection decided on the report

Signature

  1. Name and designation of person writing note
  2. Medical Council registration no.
  3. Signature / date / time of writingwrite before the patient leaves recovery

Worked example

Fictional case: Mr. H.K., 62 years, smoker, with painless haematuria and a 3 cm solitary papillary growth on the left lateral bladder wall on CT urography, upper tracts normal.

Case details

Date: 14/08/2026. Elective. OT 6.

In OT 10:00. GA induced 10:10. Scope in 10:25. Resection 10:30 to 10:55. Out of OT 11:15.

Surgeon: Dr A. (2nd-year resident, MCh Urology). Assistant: Dr B. Consultant: Dr C., present in OT.

Anaesthetist: Dr D. Scrub nurse: Sr E.

Indication and pre-op

Primary bladder tumour. CT urography: 3 x 2.5 cm papillary lesion on left lateral wall, away from left ureteric orifice; no hydronephrosis; upper tracts normal.

Urine culture sterile. Hb 12.8 g/dl, creatinine 1.1 mg/dl, sodium 138 mmol/l. Not on anticoagulants.

Consent: general, procedure-specific (including perforation, need for second resection, intravesical chemotherapy) and anaesthesia consent taken in Hindi; wife as witness.

WHO checklist sign in and time out done. Inj cefazolin 2 g IV at 10:12, before scope insertion.

Anaesthesia and position

General anaesthesia with muscle relaxant, because the tumour is on the lateral wall (to avoid obturator jerk).

Modified dorsal lithotomy. Bimanual examination under anaesthesia: no palpable mass.

Parts painted with povidone-iodine and draped. 26 Fr continuous-flow resectoscope. Monopolar, cut 120 W, coag 80 W. Irrigation 1.5% glycine at low pressure.

Findings

Urethra and prostatic urethra normal.

Single papillary tumour about 3 cm on left lateral wall, 2 cm above and lateral to the left ureteric orifice. No other lesion on 30 and 70 degree survey. No flat red areas.

Both ureteric orifices normal with clear efflux. Mild trabeculation. No diverticulum.

Procedure

Tumour resected with loop from its edges inwards in layers, with low bladder filling.

Base resected to a uniform depth into detrusor muscle, not through it. Muscle fibres seen in the base. No fat seen.

Additional deep bites from the resection bed sent separately.

Chips evacuated with Ellik evacuator.

Edges and base coagulated. Bladder emptied and resection site checked with flow off: no bleeding.

Resection visually complete. No perforation. Left ureteric orifice untouched.

Resection time 25 minutes. Glycine used 9 litres. Bimanual examination after resection: no mass.

Closure

20 Fr three-way Foley catheter, balloon 20 ml. Urine light pink. Continuous bladder irrigation with normal saline started at slow rate.

Single post-operative intravesical chemotherapy: to be instilled in recovery as per unit protocol once urine is clear, as there was no perforation. Drug, dose and dwell time to be written in the drug chart.

Specimens and implants

Container 1: tumour chips, left lateral wall, 7 g, in formalin.

Container 2: deep bites from tumour base, left lateral wall, 1 g, in formalin.

Requisition: primary tumour, single, 3 cm, papillary, left lateral wall; please comment on detrusor muscle.

End of procedure

Blood loss difficult to measure with irrigation, estimated minimal. No transfusion.

Instrument count correct, confirmed by scrub nurse.

No intra-operative complications.

Shifted to recovery in stable condition. Pulse 82/min, BP 130/80 mmHg.

Post-op orders

Pulse and BP hourly for 4 hours. Watch urine colour and catheter drainage. Inform if clots, catheter block, abdominal pain or distension.

Continuous bladder irrigation with normal saline, stop when clear.

Serum sodium this evening.

Oral fluids once awake, then normal diet.

Catheter removal and voiding trial on day 1 or 2 if urine clear.

HPE report review in OPD; decide on second-look resection and further intravesical therapy based on stage and grade.

Signature

Dr A., SR, Urology. Reg. no. ________. 14/08/2026, 11:30.

Must document for this operation

  • Number, site, size and appearance of every tumour, ideally with a bladder diagram. These decide the risk group and the follow-up plan, and the next cystoscopist compares against them.
  • Whether the resection was visually complete. Incomplete resection changes the need and timing of a second-look resection.
  • Depth of resection and whether muscle was seen and sent separately. Without detrusor muscle in the specimen the pathologist cannot separate T1 from T2 disease.
  • Bimanual examination findings under anaesthesia. A fixed mass suggests invasive disease and is part of clinical staging.
  • Perforation: none, or its type and how it was managed. It decides catheter duration, whether intravesical chemotherapy can be given, and explains later abdominal symptoms.
  • Single post-operative intravesical chemotherapy given or not, with the reason. Immediate instillation is advised when there is no perforation or heavy bleeding, so leaving it out needs a written reason.
  • Specimen containers labelled by site. Resection chips arrive unoriented, and site labels are the only way to link the report to the tumour.

Common mistakes in these notes

  • Writing 'TURBT done, chips sent' with no size, site or number of tumours.
  • Not stating whether muscle was included or whether the resection was complete.
  • No bimanual examination recorded.
  • Mixing chips from different sites in one container.
  • Not writing why intravesical chemotherapy was not given.
  • No mention of the ureteric orifices when the tumour is near the trigone.

Indian practice and paperwork

  • Discarded formalin from specimen jars is chemical waste in the yellow (f) category; tissue not sent for HPE goes in the yellow bag as human anatomical waste. (Bio-Medical Waste Management Rules 2016, CPCB guidelines)
  • A properly written operative note protects the surgeon if negligence is alleged after an operative complication; notes written after discharge have no legal value and corrections must be struck through, dated and timed. (Thomas J. Indian J Urol 2009;25(3):384-8, PMID 19881136)
  • NQAS expects the operative notes to record length of procedure, estimated blood loss, fluids given and specimen removed. (NQAS Assessor's Guidebook for District Hospitals 2020, ME E8.4)

Sources

  • Smith JA Jr, Dmochowski RR, Thomas JC, Preminger GM, et al., eds. Hinman's Atlas of Urologic Surgery. 5th ed. Elsevier; 2026, Ch 40, Transurethral resection of bladder tumors (Joshi SS, Narayan V), incl. Table 40.1 TURBT checklist, pp. 337-339.
  • Smith AD, Preminger GM, Kavoussi LR, Badlani GH, eds. Smith's Textbook of Endourology. 4th ed. Wiley; 2019, Ch 157, New techniques for resecting bladder tumors (Martov AG et al.): en bloc technique, muscularis propria, second-look resection, pp. 1806-1813.
  • Bratzler DW, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195-283. Urologic, lower tract instrumentation with risk factors for infection: fluoroquinolone, trimethoprim-sulfamethoxazole or cefazolin; cefazolin 2 g IV within 60 min before incision. academic.oup.com/ajhp/article/70/3/195/5112717
  • Hinman 5e Ch 40, printed pp. 337-338: GA with paralysis for lateral wall tumours; monopolar start at 120 W cut / 80 W coag; single-dose intravesical therapy not given if perforation suspected; catheter 20-22 Fr for large resections, removed in 1 to 7 days.

Educational template for residents. Adapt it to your institution's case-sheet format and your consultant's instructions. Patient details in the example are fictional.

This page cannot be printed from the browser. Use the Download printable PDF button on the page.